FDA Warns Hospira Again, This Time in India

Beleaguered Hospira has received an FDA warning letter following an inspection at the company’s India plant
June 5, 2013
Hospira has received another warning letter from the US FDA following an inspection at the company’s India plant in October 2012. Read the full story
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates

Related

Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Sponsored